Despite being a late entrant in the market, Emcure has leapfrogged its peers and established itself as a leading player with a niche product basket and positioning.
Emcure's portfolio is focused towards pharmaceutical products used in chronic (including sub-chronic) therapeutic areas. We are the largest pharmaceutical company in the gynecology and human immunodeficiency virus (“HIV”) antivirals therapeutic areas in India in terms of Domestic Sales for MAT September 2023.
Largest pharmaceutical company in gynecology in India
Pioneers in Chirality
Ranked 1st in the HIV antivirals therapeutic area in terms of Domestic Sales
Supplementing Health
Chirally Pure Brand
Strong Biologics Portfolio
Emerging player in this fight against chronic condition
Differentiated portfolio aiding growth
Bringing innovation for stroke